Guggenheim Maintains Buy on GeneDx Holdings, Lowers Price Target to $70
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $100 to $70.
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $100 to $70.